FIELD: medicine.
SUBSTANCE: invention relates to a method of treating infections Helicobacter pylori (H. Pylori). For the treatment of infection Helicobacter pylori (H. pylori) a compound of formula (I) is administered to the individual in an amount effective to inhibit growth H. pylori, where formula (I) represents
(I),
where R represents Q or CH2SQ, where Q represents C1–C9-alkyl, aryl, heteroaryl, aralkyl or C4–C7 cycloalkyl, and wherein Q is optionally substituted with one or more selected from halogen, OH and/or NH2-groups, or a pharmaceutically acceptable salt or ester thereof.
EFFECT: invention makes it possible to increase the effectiveness of the fight against infection.
25 cl, 1 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
METHOD OF PRODUCTION OF NUCLEOSIDE PHOSPHORYLASE AND NUCLEOSIDASE INHIBITORS | 2004 |
|
RU2334757C2 |
HETEROARYL-BIPHENYL AMINES FOR TREATING PD-L1 DISEASES | 2020 |
|
RU2837843C1 |
6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
PYRROLE AND PYRAZOLE DAAO INHIBITORS | 2004 |
|
RU2361862C2 |
AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
2-((4-(4-(BENZYLOXY)PYRIMIDIN-2-YL)PIPERAZIN-1-YL)METHYL)-1H-BENZO[d]IMIDAZOLE DERIVATIVES AS LOW-MOLECULAR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS | 2024 |
|
RU2838323C1 |
Authors
Dates
2018-08-09—Published
2015-02-06—Filed